• 中国科技期刊卓越行动计划项目资助期刊
  • 中国精品科技期刊
  • 首都科技期刊卓越行动计划
  • EI
  • Scopus
  • CAB Abstracts
  • Global Health
  • 北大核心期刊
  • DOAJ
  • EBSCO
  • 中国核心学术期刊RCCSE A+
  • 中国科技核心期刊CSTPCD
  • JST China
  • FSTA
  • 中国农林核心期刊
  • 中国开放获取期刊数据库COAJ
  • CA
  • WJCI
  • 食品科学与工程领域高质量科技期刊分级目录第一方阵T1
中国精品科技期刊2020
朱容晨,王睿瞳,陆思宇,等. 基于肠道菌群调节的花青素–大豆不溶性膳食纤维稳态体系改善糖脂代谢功能研究J. 食品工业科技,2026,47(19):1−12. doi: 10.13386/j.issn1002-0306.2025100043.
引用本文: 朱容晨,王睿瞳,陆思宇,等. 基于肠道菌群调节的花青素–大豆不溶性膳食纤维稳态体系改善糖脂代谢功能研究J. 食品工业科技,2026,47(19):1−12. doi: 10.13386/j.issn1002-0306.2025100043.
ZHU Rongchen, WANG Ruitong, LU Siyu, et al. Improvement of Glucose and Lipid Metabolism Function by a Proanthocyanidin Dietary Fiber Homeostasis System Based on Gut Microbiota RegulationJ. Science and Technology of Food Industry, 2026, 47(19): 1−12. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2025100043.
Citation: ZHU Rongchen, WANG Ruitong, LU Siyu, et al. Improvement of Glucose and Lipid Metabolism Function by a Proanthocyanidin Dietary Fiber Homeostasis System Based on Gut Microbiota RegulationJ. Science and Technology of Food Industry, 2026, 47(19): 1−12. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2025100043.

基于肠道菌群调节的花青素–大豆不溶性膳食纤维稳态体系改善糖脂代谢功能研究

Improvement of Glucose and Lipid Metabolism Function by a Proanthocyanidin Dietary Fiber Homeostasis System Based on Gut Microbiota Regulation

  • 摘要: 本研究旨在阐明花青素–大豆不溶性膳食纤维稳态体系(ACN-SIDF)通过调节肠道菌群改善高糖高脂饮食诱导糖脂代谢紊乱的作用及其机制。通过生理生化指标测定、组织病理学观察以及16S rDNA高通量测序,系统评估了ACN-SIDF对高糖高脂饮食诱导代谢紊乱小鼠的干预效果。结果显示,ACN-SIDF干预显著抑制体重增长,减少肝脏及附睾脂肪堆积,改善高血糖与胰岛素抵抗;同时降低血清中总胆固醇、甘油三酯、低密度脂蛋白胆固醇水平,提升高密度脂蛋白胆固醇浓度(P< 0.05)。在肠道功能方面,ACN-SIDF显著改善结肠与盲肠的重量、长度及组织形态,增加粪便中短链脂肪酸浓度,降低脂多糖水平(P< 0.05)。更重要的是,ACN-SIDF干预显著调节肠道菌群结构,恢复菌群多样性,提升益生菌丰度,抑制潜在致病菌扩张,体现出良好的肠道微生态调控能力。综上所述,ACN-SIDF通过调节肠道菌群及其代谢产物,在促进肠道健康的同时,实现对糖脂代谢紊乱的有效干预,展现出作为功能性膳食补充剂在预防代谢综合征中的广泛应用潜力。

     

    Abstract: This study aims to elucidate the effect and synergistic mechanism of the Anthocyanin-Soybean Insoluble Dietary Fiber steady-state system (ACN-SIDF) in ameliorating high-sugar and high-fat diet-induced glycolipid metabolism disorders by modulating the gut microbiota. The intervention effect of ACN-SIDF on mice with diet-induced metabolic disorders was systematically evaluated through physiological and biochemical index analysis, histopathological observation, and 16S rDNA high-throughput sequencing. The results showed that ACN-SIDF intervention significantly inhibited body weight gain, reduced liver and epididymal fat accumulation, and improved hyperglycemia and insulin resistance. Concurrently, it decreased serum levels of total cholesterol, triglycerides, and low-density lipoprotein cholesterol, while increasing high-density lipoprotein cholesterol concentration (P<0.05). Regarding intestinal function, ACN-SIDF significantly improved the weight, length, and tissue morphology of the colon and cecum, increased fecal short-chain fatty acid concentrations, and reduced lipopolysaccharide levels (P<0.05). More importantly, ACN-SIDF intervention significantly modulated the structure of the gut microbiota, restored microbial diversity, increased the abundance of probiotics, and suppressed the expansion of potential pathogenic bacteria, demonstrating a strong regulatory capacity on intestinal microecology. In summary, ACN-SIDF, by regulating the gut microbiota and its metabolites, effectively intervenes in glycolipid metabolism disorders while promoting intestinal health, showcasing its broad application potential as a functional dietary supplement in preventing metabolic syndrome.

     

/

返回文章
返回